{"symbol": "ALNY", "companyName": "Alnylam Pharmaceuticals Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.alnylam.com", "description": "Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.", "CEO": "John M. Maraganore", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}